Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey
dc.authorid | Yildiz Kaya, Sibel/0000-0002-6319-7889 | |
dc.contributor.author | Kurtaran, Behice | |
dc.contributor.author | Sarigul, Figen | |
dc.contributor.author | Cabalak, Mehmet | |
dc.contributor.author | Kaya, Sibel | |
dc.contributor.author | Sari, Nagehan Didem | |
dc.contributor.author | Karsen, Hasan | |
dc.contributor.author | Zerdali, Esra | |
dc.date.accessioned | 2024-09-18T21:01:54Z | |
dc.date.available | 2024-09-18T21:01:54Z | |
dc.date.issued | 2019 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description | International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) -- APR 10-14, 2019 -- Vienna, AUSTRIA | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Assoc Study Liver | en_US |
dc.description.sponsorship | Gilead Sciences Ilac Ltd. Sti. (Istanbul, Turkey) | en_US |
dc.description.sponsorship | This study was supported by Gilead Sciences Ilac Ltd. Sti. (Istanbul, Turkey). Company was not involved to the content of the study/publication; no involvement to the decision to submit for publication. | en_US |
dc.identifier.doi | 10.1016/S0618-8278(19)30424-4 | |
dc.identifier.endpage | E227 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issn | 1600-0641 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | E227 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0618-8278(19)30424-4 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/13066 | |
dc.identifier.volume | 70 | en_US |
dc.identifier.wos | WOS:000463481701006 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Journal of Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey | en_US |
dc.type | Conference Object | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1